Neither antioxidants nor genistein inhibit the progression of established atherosclerotic lesions in older apoE deficient mice

Atherosclerosis

Volumn 203, Issue 1, 2009, Pages 82-88

  Averill, Michelle M ^a   Bennett, Brian J ^a   Rattazzi, Marcello ^b   Rodmyre, Rebecca M ^a   Kirk, Elizabeth A ^a   Schwartz, Stephen M ^a   Rosenfeld, Michael E ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF PADOVA   (Italy)

Author keywords

Antioxidant; Apolipoprotein E deficient mice; Atherosclerosis; Genistein; Soy isoflavones

Indexed keywords

ALPHA TOCOPHEROL; APOLIPOPROTEIN E; ASCORBIC ACID; BETA CAROTENE; GENISTEIN;

AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; BRACHIOCEPHALIC TRUNK; C57BL 6 MOUSE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIET SUPPLEMENTATION; DISEASE COURSE; DISEASE SEVERITY; DRUG EFFECT; DRUG MECHANISM; INBRED STRAIN; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

AGING; ANIMALS; ANTIOXIDANTS; APOLIPOPROTEINS E; ATHEROSCLEROSIS; BODY WEIGHT; DISEASE PROGRESSION; GENISTEIN; ISOFLAVONES; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; SOYBEANS; TIME FACTORS;

EID: 60649120204     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2008.06.017     Document Type: Article

References (35)

1. Rimm E.B., Stampfer M.J., Ascherio A., et al. Vitamin E consumption and the risk of coronary heart disease in men. N Engl J Med 328 (1993) 1450-1456
2. Enstrom J.E., Kanim L.E., and Klein M.A. Vitamin C intake and mortality among a sample of the United States population. Epidemiology 3 (1992) 194-202
3. Nagata C. Ecological study of the association between soy product intake and mortality from cancer and heart disease in Japan. Int J Epidemiol 29 (2000) 832-836
4. Cyrus T., Yao Y., Rokach J., Tang L.X., and Pratico D. Vitamin E reduces progression of atherosclerosis in low-density lipoprotein receptor-deficient mice with established vascular lesions. Circulation 107 (2003) 521-523
5. Crawford R.S., Kirk E.A., Rosenfeld M.E., LeBoeuf R.C., and Chait A. Dietary antioxidants inhibit development of fatty streak lesions in the LDL receptor-deficient mouse. Arterioscler Thromb Vasc Biol 18 (1998) 1506-1513
6. Pratico D., Tangirala R.K., Rader D.J., Rokach J., and FitzGerald G.A. Vitamin E suppresses isoprostane generation in vivo and reduces atherosclerosis in ApoE-deficient mice. Nat Med 4 (1998) 1189-1192
7. Thomas S.R., Leichtweis S.B., Pettersson K., et al. Dietary cosupplementation with vitamin E and coenzyme Q(10) inhibits atherosclerosis in apolipoprotein E gene knockout mice. Arterioscler Thromb Vasc Biol 21 (2001) 585-593
8. Adams M.R., Golden D.L., Anthony M.S., Register T.C., and Williams J.K. The inhibitory effect of soy protein isolate on atherosclerosis in mice does not require the presence of LDL receptors or alteration of plasma lipoproteins. J Nutr 132 (2002) 43-49
9. Ni W., Tsuda Y., Sakono M., and Imaizumi K. Dietary soy protein isolate, compared with casein, reduces atherosclerotic lesion area in apolipoprotein E-deficient mice. J Nutr 128 (1998) 1884-1889
10. Vivekananthan D.P., Penn M.S., Sapp S.K., Hsu A., and Topol E.J. Use of antioxidant vitamins for the prevention of cardiovascular disease: meta-analysis of randomised trials. Lancet 361 (2003) 2017-2023
11. Sacks F.M., Lichtenstein A., Van Horn L., et al. Soy protein, isoflavones, and cardiovascular health: an American Heart Association Science Advisory for professionals from the Nutrition Committee. Circulation 113 (2006) 1034-1044
12. Rosenfeld M.E., Polinsky P., Virmani R., et al. Advanced atherosclerotic lesions in the innominate artery of the ApoE knockout mouse. Arterioscler Thromb Vasc Biol 20 (2000) 2587-2592
13. Rattazzi M., Bennett B.J., Bea F., et al. Calcification of advanced atherosclerotic lesions in the innominate arteries of ApoE-deficient mice: potential role of chondrocyte-like cells. Arterioscler Thromb Vasc Biol 25 (2005) 1420-1425
14. Kirk E.A., Sutherland P., Wang S.A., Chait A., and LeBoeuf R.C. Dietary isoflavones reduce plasma cholesterol and atherosclerosis in C57BL/6 mice but not LDL receptor-deficient mice. J Nutr 128 (1998) 954-959
15. Bea F., Blessing E., Bennett B., et al. Simvastatin promotes atherosclerotic plaque stability in ApoE-deficient mice independently of lipid lowering. Arterioscler Thromb Vasc Biol 22 (2002) 1832-1837
16. Puchtler H., and Meloan S.N. Demonstration of phosphates in calcium deposits: a modification of von Kossa's reaction. Histochemistry 56 (1978) 177-185
17. Blessing E., Campbell L.A., Rosenfeld M.E., Chesebro B., and Kuo C.C. A 6 week course of azithromycin treatment has no beneficial effect on atherosclerotic lesion development in apolipoprotein E-deficient mice chronically infected with Chlamydia pneumoniae. J Antimicrob Chemother 55 (2005) 1037-1040
18. Bea F., Blessing E., Bennett B.J., et al. Chronic inhibition of cyclooxygenase-2 does not alter plaque composition in a mouse model of advanced unstable atherosclerosis. Cardiovasc Res 60 (2003) 198-204
19. Rosenfeld M.E., Kauser K., Martin-McNulty B., et al. Estrogen inhibits the initiation of fatty streaks throughout the vasculature but does not inhibit intra-plaque hemorrhage and the progression of established lesions in apolipoprotein E deficient mice. Atherosclerosis 164 (2002) 251-259
20. Kuiper G.G., Lemmen J.G., Carlsson B., et al. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology 139 (1998) 4252-4263
21. -/- mice requires the presence of estrogen receptor-alpha. Arterioscler Thromb Vasc Biol 22 (2002) 1859-1864
22. Rufer C.E., and Kulling S.E. Antioxidant activity of isoflavones and their major metabolites using different in vitro assays. J Agric Food Chem 54 (2006) 2926-2931
23. Dixon R.A., and Ferreira D. Genistein. Phytochemistry 60 (2002) 205-211
24. Chen X.W., Garner S.C., and Anderson J.J. Isoflavones regulate interleukin-6 and osteoprotegerin synthesis during osteoblast cell differentiation via an estrogen-receptor-dependent pathway. Biochem Biophys Res Commun 295 (2002) 417-422
25. Viereck V., Grundker C., Blaschke S., et al. Phytoestrogen genistein stimulates the production of osteoprotegerin by human trabecular osteoblasts. J Cell Biochem 84 (2002) 725-735
26. Kagan V.E., Serbinova E.A., Forte T., Scita G., and Packer L. Recycling of vitamin E in human low density lipoproteins. J Lipid Res 33 (1992) 385-397
27. Donaldson W.E. Atherosclerosis in cholesterol-fed Japanese quail: evidence for amelioration by dietary vitamin E. Poult Sci 61 (1982) 2097-2102
28. Nunes G.L., Sgoutas D.S., Redden R.A., et al. Combination of vitamins C and E alters the response to coronary balloon injury in the pig. Arterioscler Thromb Vasc Biol 15 (1995) 156-165
29. Weinberg P.D. Analysis of the variable effect of dietary vitamin E supplements on experimental atherosclerosis. J Plant Physiol 162 (2005) 823-833
30. Verlangieri A.J., and Bush M.J. Effects of d-alpha-tocopherol supplementation on experimentally induced primate atherosclerosis. J Am Coll Nutr 11 (1992) 131-138
31. Stocker R., and Keaney Jr. J.F. Role of oxidative modifications in atherosclerosis. Physiol Rev 84 (2004) 1381-1478
32. VanderLaan P.A., Reardon C.A., and Getz G.S. Site specificity of atherosclerosis: site-selective responses to atherosclerotic modulators. Arterioscler Thromb Vasc Biol 24 (2004) 12-22
33. Mukherjee D., Nissen S.E., and Topol E.J. Risk of cardiovascular events associated with selective COX-2 inhibitors. JAMA 286 (2001) 954-959
34. Hulley S., et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. JAMA 280 (1998) 605-613
35. The Women's Health Initiative Steering Committee. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the women's health initiative randomized controlled trial. JAMA 291 (2004) 1701-1712